Search Results 181-190 of 16128 for pharmacogenetics
On Saturday, Oct. 5, we will broadcast from the Individualizing Medicine Conference, in Rochester, Minn. We'll discuss how the promise of genomic medicine has ...
The purpose of this study is to identify early response biomarkers from biological or functional imaging to better align with clinical trial endpoints and ...
Faculty and staff of the Pharmacogenomics and Drug Targets Lab of Liewei Wang, M.D., Ph.D., at Mayo Clinic's campus in Minnesota.
The purpose of this study is to determine if genetic analysis of participants treated with ECT will identify gene loci associated with severe mood disorders, ...
This study is designed to explore the experiences of individuals growing up with a genetic diagnosis of SCAs and their families. Participation eligibility.
This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...
Dr. Kullo's lab investigates family history, linkage studies, candidate gene-association studies, genome-wide association studies and genome sequencing.
The purpose of this study is to evaluate the integration of cancer pan-genetic testing into a cancer clinical practice and understand both its use and effect in ...
Research in the Division of Experimental Pathology and Laboratory Medicine at Mayo Clinic seeks to reveal the mechanisms underlying disease development and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.